Exhibit 1 - Agenda Information SheetCity of Denton
_____________________________________________________________________________________
AGENDA INFORMATION SHEET
DEPARTMENT: Procurement
CFO: Cassey Ogden
DATE: September 20, 2022
SUBJECT
Consider adoption of an ordinance of the City of Denton, a Texas home-rule municipal corporation,
authorizing the City Manager to execute a contract with Genomic Life, Inc., for the Cancer Guardian
Program services with a monthly voluntary rate of $20.00 per employee or $40.00 per employee and spouse
for the City of Denton employees; providing for the expenditure of funds therefor; and providing an
effective date of January 1, 2023 (RFP 7979 – awarded to Genomic Life, Inc., for three (3) years, with the
option for two (2) additional one (1) year extensions, in the total five (5) year not-to-exceed amount of
$340,000.00).
INFORMATION/BACKGROUND
Due to the rising cost of cancer claims on the City’s health plans, the City introduced the Cancer Guardian
program to our employees effective September 1, 2021. The Cancer Guardian program is not insurance but
instead is a program that provides resources and DNA testing for pre-diagnosis of cancer and provides
resources and tools when a cancer diagnosis is made.
The Cancer Guardian program information was provided to the City by ACAP HealthWorks during the
introduction of Armor Up America for First Responders (formerly Responder Health). The Cancer
Guardian program is a niche service; therefore, there is no marketing analysis.
The City implemented the Cancer Guardian program mid-year with a special open enrollment in August
2021, for a September 1, 2021 effective date.
Because the Cancer Guardian program was new to the City of Denton benefits offerings, based on past
experience with other voluntary products, we estimated the first year’s total spend to be under $50,000,
which is below the threshold requiring a formal solicitation process. During the open enrollment period for
the 2022 plan year, the response for the Cancer Guardian program was far better than anticipated, and
enrollment exceeded expectations. The monthly expenditure amount for the 2022 plan year is
approximately $4,167 per month, which results in a higher than anticipated first-year cost.
Because the current Genomic Life contract is interim only, the City conducted a formal RFP process to
receive bids for a new multi-year Cancer Guardian Program contract for the 2023 plan year to be effective
January 1, 2023. The City received one proposal from Genomic Life, the incumbent vendor.
City Hall
215 E. McKinney Street
Denton, Texas
www.cityofdenton.com
Project Description Estimated 5-Year Expenditure
Year 1* (208 plus 10% = 229 count) $ 56,000
Year 2* (252 count) $ 61,000
Year 3* (277 count) $ 67,000
Year 4* (305 count) $ 74,000
Year 5* (335 count) $ 82,000
Total $340,000
*10% member increase each year, starting with the 2022 average count
Request for Proposals was sent to 90 prospective suppliers, including two (2) Denton firms. In addition,
specifications were placed on the Procurement website for prospective suppliers to download and advertised
in the local newspaper. One (1) proposal was received, and references were checked to ensure the vendor
can provide the services requested in the Scope of Work. The proposal was evaluated based upon published
criteria including compliance with specifications, probable performance, and price. The department is
awarding the contract to Genomic Life, Inc.
NIGP Code Used for Solicitation: 946 - (Service Only) - Financial
Services & 953 - (Service Only) -
Management Services
Notifications sent for Solicitation sent in IonWave: 90
Number of Suppliers that viewed Solicitation in IonWave: 8
HUB-Historically Underutilized Business Invitations sent out: 6
SBE-Small Business Enterprise Invitations sent out: 21
Responses from Solicitation: 1
RECOMMENDATION
Award a contract to Genomic Life, Inc., for the Cancer Guardian Program services with a monthly voluntary
rate of $20.00 per employee or $40.00 per employee and spouse for the City of Denton employees, in a
three (3) year, with the option for two (2) additional one (1) year extensions, in the total five (5) year not-
to-exceed amount of $340,000.
PRINCIPAL PLACE OF BUSINESS
Genomic Life, Inc.
San Diego, CA
ESTIMATED SCHEDULE OF PROJECT
This is an initial three (3) year contract with options to extend the contract for two (2) additional one (1)
year periods, with all terms and conditions remaining the same, starting on January 1, 2023.
FISCAL INFORMATION
The Cancer Guardian program services are funded 100% by employees through payroll deduction. The City
does not contribute to the premiums for voluntary products.
EXHIBITS
Exhibit 1: Agenda Information Sheet
Exhibit 2: Ordinance and Contract
Respectfully submitted:
Lori Hewell, 940-349-7100
Purchasing Manager
For information concerning this acquisition, contact: Linda Kile, 940-349-8388.
Legal point of contact: Marcella Lunn at 940-349-8333.